Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.

Neurology - 10 May 2005

Dufouil C, Richard F, Fiévet N, Dartigues J F, Ritchie K, Tzourio C, Amouyel P, Alpérovitch A

Abstract excerpt

OBJECTIVE: To examine the association of plasma cholesterol levels, lipid-lowering agent (LLA) intake, and APOE genotype with dementia prevalence. METHODS: The Three-City Study is a population-based cohort of 9,294 subjects selected from the electoral rolls of three French cities (Bordeaux, Dijon, Montpellier). Baseline examination included extensive assessment of exposure to vascular risk factors (including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Causality
Share to Dementia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to France

Share to Health Surveys

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hyperlipidemias

Share to Hypolipidemic Agents

Source

Identifiers

PMID: 15883313
DOI: 10.1212/01.WNL.0000160114.42643.31

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.PMID 15883313Read ↗

Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementiaSemantic proximity Read ↗

Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.Semantic proximity Read ↗

APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.Semantic proximity Read ↗

The diagnostic value investigation of blood lipid as biomarker combined with apolipoprotein E genotype in dementia with Lewy bodies.Semantic proximity Read ↗

Association of blood lipids, atherosclerosis and statin use with dementia after strokeSemantic proximity Read ↗

The role of dementia in the association between APOE4 and all-cause mortality: pooled analyses of two population-based cohort studies.Semantic proximity Read ↗

A multivariable Mendelian randomisation study of serum lipids and dementia risk within the UK BiobankSemantic proximity Read ↗

Sex and APOE Genotype Differences Related to Statin Use in The Aging PopulationSemantic proximity Read ↗

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.Semantic proximity Read ↗

Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohortSemantic proximity Read ↗

Genetic insights of lipid metabolism and lipid-lowering drugs with Lewy body dementia risk: Evidence from Mendelian randomization.Semantic proximity Read ↗

Association of statins use and genetic susceptibility with incidence of Alzheimer's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.